Tapestry, Inc.
Congress has disclosed 8 buys and 20 sells of TPR (Tapestry, Inc.) in official financial disclosures, each linked to its original filing. A transparency record — not investment advice.
Activity Congressional Activity
Round-trip watch Still on the books
Members who disclosed buying TPR and have not disclosed selling, versus their own entry (the most recent disclosed buy). "Open" means no disclosed sale — never "still holds" — and the % is unrealised, on paper. Not investment advice.
| Member | Entry (last buy) | Entry price | Now | vs entry | Status |
|---|---|---|---|---|---|
| Alan Armstrong | 2026-03-27 | $137.92 | $117.64 | -14.7% | underwater |
Price as of 2026-11-02. Counted open while disclosed buys outnumber disclosed sells; tracks the price, not exact position size (amounts are ranges).
Fundamentals · FY2026 Valuation
Standard valuation multiples from SEC-reported GAAP financials (trailing twelve months), each compared to the median for Materials. We use reported GAAP, not forward or adjusted earnings, so our figures can sit higher than sites that do — especially for companies with falling profit. Relative context — not a target price or investment advice.
how it's calculated
how it's calculated
how it's calculated
28 trades Recent Congressional Trades
Two things to watch per trade: the disclosure lag (how many days passed before the trade was made public) and the price move in that window (how the stock moved during those non-public days). A sell followed by a price drop, or a buy followed by a rise, means well-timed trading — visible here in the open. Note: the Score measures how notable a trade is, not whether it made money — the price move is shown for context and isn't part of it.
| Politician | Chamber | Type | Owner | Date | Disclosure lag | Price move in that window | Amount | Score | Source |
|---|---|---|---|---|---|---|---|---|---|
| Matthew Robert Van Epps | House | SELL ◆ insider convergence | Self · Schwab One Account | 2026-06-16 | 1 days | -2.4% | $15K–$50K | 96.3 | ↗ filing |
| Alan Armstrong | Senate | BUY ◆ insider divergence · moderate | Self | 2026-03-27 | 116 days | +2.7% | $1K–$15K | 82.9 | ↗ eFD |
| Terri Sewell | House | SELL ◆ insider convergence · moderate | Self | 2026-03-25 | 1 days | -3.3% | $15K–$50K 15.4% of NW 🔥 |
99.9 | ↗ filing |
| Michael McCaul | House | SELL OCR ◆ insider convergence · moderate | Spouse | 2025-11-14 | 21 days | +15.1% | $50K–$100K | 29.5 | ↗ filing |
| Michael McCaul | House | SELL OCR ◆ insider convergence · moderate | Spouse | 2025-09-26 | 9 days | +5.4% | $50K–$100K | 29.8 | ↗ filing |
| Julia Letlow | House | SELL ◆ insider convergence | Self · Merrill Lynch Investment Account #025 | 2025-07-29 | 13 days | +0.5% | $1K–$15K 1.0% of NW |
29.9 | ↗ filing |
| Michael McCaul | House | SELL OCR ◆ insider convergence | Spouse | 2025-07-24 | 12 days | +2.8% | $50K–$100K | 49.3 | ↗ filing |
| Michael McCaul | House | SELL OCR ◆ insider convergence · moderate | Spouse | 2025-01-23 | 13 days | -0.3% | $100K–$250K | 50.9 | ↗ filing |
| Michael McCaul | House | SELL OCR ◆ insider convergence · moderate | Spouse | 2024-12-13 | 23 days | +5.6% | $50K–$100K | 50.9 | ↗ filing |
| Julia Letlow | House | SELL ◆ insider convergence · moderate | Self · Merrill Lynch Investment Account #025 | 2024-11-26 | 258 days | +79.3% | $1K–$15K 1.0% of NW |
49.9 | ↗ filing |
| Julia Letlow | House | BUY ◆ insider divergence · moderate | Self · Merrill Lynch Investment Account #025 | 2024-10-23 | 292 days | +151.5% | $1K–$15K 1.0% of NW |
66.0 | ↗ filing |
| Michael McCaul | House | BUY OCR | Spouse | 2024-08-19 | 17 days | +1.3% | $50K–$100K | 34.0 | ↗ filing |
| Michael McCaul | House | SELL OCR ◆ insider convergence | Spouse | 2024-04-03 | 33 days | — | $100K–$250K | 58.4 | ↗ filing |
| Michael McCaul | House | SELL OCR | Spouse | 2024-01-19 | 17 days | — | $1K–$15K | 22.3 | ↗ filing |
| Michael McCaul | House | BUY OCR | Spouse | 2023-08-15 | 21 days | — | $50K–$100K | 61.4 | ↗ filing |
| Josh Gottheimer | House | SELL | Joint · Morgan Stanley - Select UMA Account # 1 | 2023-08-10 | 28 days | — | $1K–$15K <0.1% of NW |
6.8 | ↗ filing |
| Josh Gottheimer | House | SELL | Joint · Morgan Stanley - Select UMA Account # 1 | 2023-05-19 | 18 days | — | $1K–$15K <0.1% of NW |
8.6 | ↗ filing |
| Michael McCaul | House | SELL OCR | Spouse | 2023-03-01 | 36 days | — | $100K–$250K | 96.7 | ↗ filing |
| Josh Gottheimer | House | SELL | Joint · Morgan Stanley - Select UMA Account # 1 | 2022-04-14 | 20 days | — | $1K–$15K <0.1% of NW |
10.6 | ↗ filing |
| Josh Gottheimer | House | SELL | Joint | 2021-11-02 | 34 days | — | $1K–$15K <0.1% of NW |
15.7 | ↗ filing |
| Josh Gottheimer | House | BUY | Joint | 2021-07-27 | 10 days | — | $1K–$15K <0.1% of NW |
22.3 | ↗ filing |
| Josh Gottheimer | House | BUY | Joint | 2021-03-17 | 21 days | — | $1K–$15K <0.1% of NW |
40.5 | ↗ filing |
| Josh Gottheimer | House | BUY | Joint | 2021-02-16 | 17 days | — | $1K–$15K <0.1% of NW |
75.9 | ↗ filing |
| Tom Malinowski | House | SELL | Self | 2019-09-24 | 7 days | — | $15K–$50K 2.2% of NW |
96.4 | ↗ filing |
| Earl Blumenauer | House | SELL | Spouse | 2019-09-12 | 34 days | — | $1K–$15K 0.1% of NW |
93.1 | ↗ filing |
| Greg Gianforte | House | SELL | Self | 2019-09-11 | 5 days | — | $15K–$50K | 96.4 | ↗ filing |
| John Rutherford | House | BUY | Self | 2019-04-24 | 6 days | — | $1K–$15K 0.8% of NW |
75.9 | ↗ filing |
| Bill Flores | House | SELL | Self | 2017-12-27 | 16 days | — | $1K–$15K | 75.9 | ↗ filing |
Corporate insiders · SEC Form 4 Insider Activity
What the company's own officers and directors did in TPR — open-market purchases and sales from SEC Form 4 filings (option exercises, grants and tax withholding are excluded). This is context for the congressional activity above, never a buy/sell signal, and the two datasets are kept separate on purpose. Does convergence mean anything? →
Of the congressional trades in TPR, 10 coincided with corporate insiders moving the same way within 60 days, and 2 with insiders moving the opposite way. This is co-occurrence only — whether it carries any edge is tested honestly on the convergence page.
| Date | Insider | Role | Type | Size | Source |
|---|---|---|---|---|---|
| 2026-09-09 | Kulikowsky Denise | C-suite | SELL | $253K | ↗ EDGAR |
| 2026-09-09 | Kulikowsky Denise | C-suite | SELL | $417K | ↗ EDGAR |
| 2026-08-19 | Crevoiserat Joanne C. | C-suite | SELL 10b5-1 | $1.7M | ↗ EDGAR |
| 2026-08-19 | Crevoiserat Joanne C. | C-suite | SELL 10b5-1 | $1.9M | ↗ EDGAR |
| 2026-05-26 | Kahn Todd | C-suite | SELL | $2.7M | ↗ EDGAR |
| 2026-05-13 | Crevoiserat Joanne C. | C-suite | SELL 10b5-1 | $1.7M | ↗ EDGAR |
| 2026-05-13 | Crevoiserat Joanne C. | C-suite | SELL 10b5-1 | $2.0M | ↗ EDGAR |
| 2026-03-03 | Dadlani Manesh | Other | SELL | $152K | ↗ EDGAR |
| 2026-02-18 | Crevoiserat Joanne C. | C-suite | SELL 10b5-1 | $2.1M | ↗ EDGAR |
| 2026-02-18 | Crevoiserat Joanne C. | C-suite | SELL 10b5-1 | $2.3M | ↗ EDGAR |
| 2026-02-18 | Crevoiserat Joanne C. | C-suite | SELL 10b5-1 | $3.2M | ↗ EDGAR |
| 2026-02-17 | Greco Thomas | Director | SELL | $622K | ↗ EDGAR |
| 2026-02-17 | Greco Thomas | Director | SELL | $763K | ↗ EDGAR |
| 2026-02-17 | Greco Thomas | Director | SELL | $815K | ↗ EDGAR |
| 2026-02-11 | Dadlani Manesh | Other | SELL | $18K | ↗ EDGAR |
| 2026-02-11 | Dadlani Manesh | Other | SELL | $312K | ↗ EDGAR |
| 2026-02-10 | Kulikowsky Denise | C-suite | SELL | $502K | ↗ EDGAR |
| 2026-02-10 | Kulikowsky Denise | C-suite | SELL | $924K | ↗ EDGAR |
| 2026-02-10 | Gates Anne | Director | SELL | $999K | ↗ EDGAR |
| 2026-02-10 | Roe Scott A. | C-suite | SELL | $1.6M | ↗ EDGAR |
| 2026-02-10 | Roe Scott A. | C-suite | SELL | $2.3M | ↗ EDGAR |
| 2026-02-10 | Roe Scott A. | C-suite | SELL | $2.9M | ↗ EDGAR |
| 2026-02-09 | Kahn Todd | C-suite | SELL | $2.1M | ↗ EDGAR |
| 2026-02-09 | Kahn Todd | C-suite | SELL | $4.0M | ↗ EDGAR |
| 2025-12-04 | Kulikowsky Denise | C-suite | SELL | $67K | ↗ EDGAR |
Combined timeline — Congress & insiders
Both sets of trades on one timeline, newest first, so you can see when they lined up. Congress vs ◆ insider.
| Date | Who | Type | Size | |
|---|---|---|---|---|
| ◆ insider | 2026-09-09 | Kulikowsky Denise C-suite | SELL | $253K |
| ◆ insider | 2026-09-09 | Kulikowsky Denise C-suite | SELL | $417K |
| ◆ insider | 2026-08-19 | Crevoiserat Joanne C. C-suite 10b5-1 | SELL | $1.7M |
| ◆ insider | 2026-08-19 | Crevoiserat Joanne C. C-suite 10b5-1 | SELL | $1.9M |
| Congress | 2026-06-16 | Matthew Robert Van Epps | SELL | $15K–$50K |
| ◆ insider | 2026-05-26 | Kahn Todd C-suite | SELL | $2.7M |
| ◆ insider | 2026-05-13 | Crevoiserat Joanne C. C-suite 10b5-1 | SELL | $1.7M |
| ◆ insider | 2026-05-13 | Crevoiserat Joanne C. C-suite 10b5-1 | SELL | $2.0M |
| Congress | 2026-03-27 | Alan Armstrong | BUY | $1K–$15K |
| Congress | 2026-03-25 | Terri Sewell | SELL | $15K–$50K |
| ◆ insider | 2026-03-03 | Dadlani Manesh Other | SELL | $152K |
| ◆ insider | 2026-02-18 | Crevoiserat Joanne C. C-suite 10b5-1 | SELL | $2.1M |
| ◆ insider | 2026-02-18 | Crevoiserat Joanne C. C-suite 10b5-1 | SELL | $2.3M |
| ◆ insider | 2026-02-18 | Crevoiserat Joanne C. C-suite 10b5-1 | SELL | $3.2M |
| ◆ insider | 2026-02-17 | Greco Thomas Director | SELL | $622K |
| ◆ insider | 2026-02-17 | Greco Thomas Director | SELL | $763K |
| ◆ insider | 2026-02-17 | Greco Thomas Director | SELL | $815K |
| ◆ insider | 2026-02-11 | Dadlani Manesh Other | SELL | $18K |
| ◆ insider | 2026-02-11 | Dadlani Manesh Other | SELL | $312K |
| ◆ insider | 2026-02-10 | Kulikowsky Denise C-suite | SELL | $502K |
| ◆ insider | 2026-02-10 | Kulikowsky Denise C-suite | SELL | $924K |
| ◆ insider | 2026-02-10 | Gates Anne Director | SELL | $999K |
| ◆ insider | 2026-02-10 | Roe Scott A. C-suite | SELL | $1.6M |
| ◆ insider | 2026-02-10 | Roe Scott A. C-suite | SELL | $2.3M |
FAQ Common questions
How much has Congress traded TPR?
8 disclosed buys and 20 sells of TPR (Tapestry, Inc.) appear in official congressional financial disclosures.
Is it legal for members of Congress to trade TPR?
Members of Congress may trade stocks but must disclose it under the STOCK Act. QuantCapitol tracks those public disclosures for transparency — nothing here is an accusation of wrongdoing or investment advice.
Where does this data come from?
Official US House Clerk and Senate electronic financial disclosures. Every trade links back to its original filing so you can verify it yourself.